Article Information
History
- September 8, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Monika Krzak*,1,
- Tobi Alegbe*,1,
- D Leland Taylor*,2,
- Mennatallah Ghouraba1,
- Michelle Strickland1,
- Reem Satti1,
- Tina Thompson3,
- Kenneth Arestang3,
- Moritz J Przybilla1,
- Lucia Ramirez-Navarro1,
- Bradley T Harris1,
- Kimberly Ai Xian Cheam4,
- Guillaume Noell,
- Steven Leonard1,
- Velislava Petrova5,
- Carla Jones-Bell1,
- Kylie R James6,
- Noor Wana1,
- May Xueqi Hu1,
- Jason Skelton7,
- Jasmin Ostermayer1,
- Yong Gu1,
- Claire Dawson3,
- Daniele Corridoni8,9,
- Cristina Cotobal Martin1,
- Miles Parkes3,
- Vivek Iyer1,
- Gareth-Rhys Jones10,
- Rebecca E. McIntyre11,
- Tim Raine☥,3,† and
- Carl A Anderson☥,1,12,†
- 1Wellcome Sanger Institute, Hinxton CB10 1SA, UK
- 2Center for Precision Health Research, National Human Genome Research Institute, Bethesda MD 20892, US
- 3Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK
- 4UK Dementia Research Institute, University of Cambridge, Cambridge CB2 0AH, UK
- 5Ministry of Foreign Affairs of the Republic of Bulgaria
- 6Garvan institute of medical research, Darlinghurst NSW 2010, Australia
- 7Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge CB2 0RE, UK
- 8Sanofi R&D, The Bennet Building, Babraham Research Campus, Cambridge, CB22 3AT, United Kingdom
- 9MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom
- 10University of Edinburgh Centre for Inflammation Research, Queens Medical Research institute, Edinburgh EH16 4TJ, UK
- 11Relation Therapeutics, London NW1 3BT, UK
- ↵†Correspondence: ca3{at}sanger.ac.uk C.A.A., tr223{at}cam.ac.uk T.R.
↵* These authors contributed equally to this work